Class II

Drug Recall: Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy

Boothwyn Pharmacy LLC · July 9, 2025

Reason for Recall

Subpotent Drug

Distribution

U.S. Nationwide

States Affected

NATIONWIDE

Quantity Affected

642 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0606-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.